A fierce debate has erupted over investment-linked insurance plans.
Are ILPs misunderstood tools for long-term wealth, or overly complex, high-cost products investors should avoid?
Christopher Tan, CEO of Providend, returns to address his criticisms of his arguments following his Business Times column, which challenged the value of ILPs.
He breaks down industry rebuttals on compounding bonuses, adviser fees, and fund access, and explains why his firm continues to steer clear of them.
Hear both sides of the ILP story, from consumer confusion to claims of strategic tax and estate planning benefits - and decide where you stand.
Hosted by Michelle Martin.

Money and Me: What you need to know about CPF’s 2028 new investment scheme today!
18:31

Market View: Oil War Shockwaves - Why Insurance, Defense and AI Are Suddenly Market Movers
20:57

Money and Me: Expensive Mistakes When Market Shocks Hit
25:57